Pataky RE
ORCID: 0000-0003-0159-582X
· 1 paper in corpus
Niraparib was recently funded in Canada for the maintenance treatment of ovarian cancer following platinum-based chemotherapy. However, the drug's safety profile in the real world remains uncertain. We conducted a cohort study to describe t…